Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Iron oxide nanoparticles for magnetically guided and magnetically responsive drug delivery

Vista senzilla d'ítem
dc.contributor.authorEstelrich i Latràs, Joan
dc.contributor.authorEscribano Ferrer, Elvira
dc.contributor.authorQueralt i Regué, Josep
dc.contributor.authorBusquets i Viñas, Ma. Antonia
dc.date.accessioned2020-02-06T10:22:53Z
dc.date.available2020-02-06T10:22:53Z
dc.date.issued2015-04-10
dc.date.updated2020-02-06T10:22:54Z
dc.description.abstractIn this review, we discuss the recent advances in and problems with the use of magnetically-guided and magnetically-responsive nanoparticles in drug delivery and magnetofection. In magnetically-guided nanoparticles, a constant external magnetic field is used to transport magnetic nanoparticles loaded with drugs to a specific site within the body or to increase the transfection capacity. Magnetofection is the delivery of nucleic acids under the influence of a magnetic field acting on nucleic acid vectors that are associated with magnetic nanoparticles. In magnetically-responsive nanoparticles, magnetic nanoparticles are encapsulated or embedded in a larger colloidal structure that carries a drug. In this last case, an alternating magnetic field can modify the structure of the colloid, thereby providing spatial and temporal control over drug release.
dc.format.extent32 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec649194
dc.identifier.issn1661-6596
dc.identifier.pmid25867479
dc.identifier.urihttps://hdl.handle.net/2445/149424
dc.language.isoeng
dc.publisherMDPI
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/ijms16048070
dc.relation.ispartofInternational Journal of Molecular Sciences, 2015, vol. 16, num. 4, p. 8070-8101
dc.relation.urihttps://doi.org/10.3390/ijms16048070
dc.rightscc-by (c) Estelrich i Latràs, Joan et al., 2015
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)
dc.subject.classificationNanopartícules
dc.subject.classificationLiposomes
dc.subject.classificationQuimioteràpia
dc.subject.classificationÒxid de ferro
dc.subject.otherNanoparticles
dc.subject.otherLiposomes
dc.subject.otherChemotherapy
dc.subject.otherFerric oxide
dc.titleIron oxide nanoparticles for magnetically guided and magnetically responsive drug delivery
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Miniatura
Nom:
649194.pdf
Mida:
2.4 MB
Format:
Adobe Portable Document Format
Descarregar

Col·leccions

Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)
Articles publicats en revistes (Bioquímica i Fisiologia)
Articles publicats en revistes (Institut de Nanociència i Nanotecnologia (IN2UB))